Metropolitan Life Insurance Company (MetLife)’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,989
Closed -$29.6K 646
2024
Q1
$29.6K Sell
3,989
-822
-17% -$6.1K ﹤0.01% 1668
2023
Q4
$48.7K Hold
4,811
﹤0.01% 1461
2023
Q3
$37.5K Buy
4,811
+1,008
+27% +$7.86K ﹤0.01% 1567
2023
Q2
$31.3K Buy
3,803
+680
+22% +$5.6K ﹤0.01% 1695
2023
Q1
$22.6K Sell
3,123
-1,441
-32% -$10.4K ﹤0.01% 1823
2022
Q4
$40.5K Hold
4,564
﹤0.01% 1598
2022
Q3
$55.9K Hold
4,564
﹤0.01% 1391
2022
Q2
$54K Hold
4,564
﹤0.01% 1456
2022
Q1
$86.8K Sell
4,564
-13,546
-75% -$258K ﹤0.01% 1284
2021
Q4
$481K Hold
18,110
0.01% 1461
2021
Q3
$744K Sell
18,110
-1,147
-6% -$47.1K 0.01% 1173
2021
Q2
$1.09M Buy
19,257
+1,084
+6% +$61.4K 0.02% 942
2021
Q1
$763K Buy
18,173
+810
+5% +$34K 0.01% 1140
2020
Q4
$1.22M Sell
17,363
-946
-5% -$66.3K 0.02% 757
2020
Q3
$514K Buy
18,309
+1,734
+10% +$48.7K 0.01% 1201
2020
Q2
$490K Hold
16,575
0.01% 1214
2020
Q1
$329K Hold
16,575
0.01% 1307
2019
Q4
$491K Hold
16,575
0.01% 1339
2019
Q3
$377K Buy
16,575
+1,287
+8% +$29.3K 0.01% 1466
2019
Q2
$378K Buy
15,288
+342
+2% +$8.46K 0.01% 1483
2019
Q1
$365K Hold
14,946
0.01% 1496
2018
Q4
$340K Hold
14,946
0.01% 1475
2018
Q3
$476K Hold
14,946
0.01% 1400
2018
Q2
$536K Buy
14,946
+3,192
+27% +$114K 0.01% 1273
2018
Q1
$390K Hold
11,754
0.01% 1442
2017
Q4
$361K Sell
11,754
-12,248
-51% -$376K ﹤0.01% 1501
2017
Q3
$576K Hold
24,002
﹤0.01% 1587
2017
Q2
$403K Buy
+24,002
New +$403K ﹤0.01% 1863
2016
Q3
Sell
-7,426
Closed -$181K 2640
2016
Q2
$181K Buy
+7,426
New +$181K ﹤0.01% 2384